本頁面由Tiger Trade Technology Pte. Ltd.提供服務

神經分泌生物科學

149.50
-0.5200-0.35%
盤前150.701.20+0.80%05:58 EDT
成交量:101.58萬
成交額:1.52億
市值:152.49億
市盈率:21.91
高:151.31
開:150.34
低:149.00
收:150.02
52周最高:186.12
52周最低:122.14
股本:1.02億
流通股本:9,999.56萬
量比:1.03
換手率:1.02%
股息:- -
股息率:- -
每股收益(TTM):6.82
每股收益(LYR):4.67
淨資產收益率:22.09%
總資產收益率:11.70%
市淨率:4.13
市盈率(LYR):32.01

資料載入中...

2026/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/31

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/07/31

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/31

重要事件披露

Form 8-K/A - Current report: [Amend]
2026/07/30

重要事件披露

Form 8-K - Current report
2026/07/27

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/28

重要事件披露

Form 8-K - Current report
2026/05/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities